Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.665 USD | +8.12% | -0.60% | +89.77% |
05:21pm | Atossa Therapeutics Doses Last Patient in Phase 2 Karisma-Endoxifen Trial | MT |
13/05 | Atossa Therapeutics Files $100 Million Mixed-Shelf Offering | MT |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- MarketScreener Editorial Features